United Kingdom· GB-APID-36815511000001102
Mekinist 2mg tablets
A trametinib product containing trametinib, registered in United Kingdom by Originalis B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Trametinib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01EE01 (trametinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Trametinib · ATC L01EE01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of trametinib costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trametinib · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$215.55
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Trametinib
- Manufacturer
- Originalis B.V.
- Country
- United Kingdom (GB)
- ATC code
- L01EE01
- ATC class
- Trametinib
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin08719923003730
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for trametinib.
Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trametinib · interactions on record
22 records
- 22 moderate
Most severe, free to view
- FostamatinibB02BX09moderate
- ElagolixH01CC03moderate
- SarecyclineJ01AA14moderate
- IsavuconazoleJ02AC05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trametinib in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaMEKINISTNOVARTIS PHARMACEUTICALS CANADA INC
- SwitzerlandMekinist 0.5 mg, FilmtablettenNovartis Pharma Schweiz AG
- NetherlandsMekinist 0,5 mg filmomhulde tabletNovartis Europharm Limited
- SpainMEKINIST 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- NorwayMekinistNovartis Europharm Limited (1)
- PolandMekinistNovartis Europharm Limited
- SwedenMekinist 0,5 mg Filmdragerad tablettNovartis Europharm Limited
- IrelandMekinist 0.5 mg film-coated tabletsNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mekinist, Spexotras
- Liechtenstein · Mekinist, Spexotras
- Norway · Mekinist, Spexotras
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aebba048-1824-4ee3-a0e2-df07525ec2bb GET /v1/drugs/aebba048-1824-4ee3-a0e2-df07525ec2bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "36815511000001102",
"desc": "Mekinist 2mg tablets (Originalis B.V.)",
"form": "Oral tablet",
"vpid": "25964511000001108",
"source": "dmd",
"vtm_id": "777818003",
"strength": "2 mg",
"substance": "Trametinib",
"ingredient": "Trametinib dimethyl sulfoxide",
"supplier_code": "36751511000001108"
}See everything about trametinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.